Sfoglia per AUTORE
ROSIñOL L
Collezione AOU Città della Salute di Torino

  

Items : 6

European Myeloma Network Group review and consensus statement on primary plasma cell leukemia. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2025 Apr;36(4):361-374. doi: 10.1016/j.annonc.2025.01.022. Epub 2025 Feb 7.
2025
AOU Città della Salute di Torino

Musto P; Engelhardt M; van de Donk NWCJ; Gay F; Terpos E; Einsele H; Fernández de Larrea C; Sgherza N; Bolli N; Katodritou E; Gentile M; Royer B; Derudas D; Jelinek T; Zamagni E; Rosiñol L; Paiva B; Caers J; Kaiser M; Beksac M; Hájek R; Spencer A; Ludwig H; Cavo M; Bladé J; Moreau P; Mateos MV; San-Miguel JF; Dimopoulos MA; et alii...

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma. in The New England journal of medicine / N Engl J Med. 2024 Jan 25;390(4):301-313. doi: 10.1056/NEJMoa2312054. Epub 2023 Dec 12.
2024
AOU Città della Salute di Torino

Moreau P; Bladé J; Rodriguez-Otero P; Carson R; de Boer CJ; Sitthi-Amorn A; Vanquickelberghe V; van Brummelen EMJ; Vieyra D; Wang J; Liu Y; Ahmadi T; Lonergan S; Jurczyszyn A; Hajek R; Spencer A; Einsele H; Vangsted A; Silzle T; Roeloffzen W; Delforge M; Rosiñol L; Sureda Balari A; Schjesvold F; Katodritou E; van de Donk NWCJ; Nijhof IS; Mina R; Gay F; et alii...

A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma. in Future oncology (London, England) / Future Oncol. 2024;20(38):3043-3063. doi: 10.1080/14796694.2024.2394323. Epub 2024 Sep 17.
2024
AOU Città della Salute di Torino

Sonneveld P; Dimopoulos MA; Boccadoro M; Quach H; Ho PJ; Beksac M; Hulin C; Antonioli E; Leleu X; Mangiacavalli S; Perrot A; Cavo M; Belotti A; Broijl A; Gay F; Mina R; van de Donk NWCJ; Katodritou E; Schjesvold F; Balari AS; Rosiñol L; Delforge M; Roeloffzen W; Silzle T; Vangsted A; Einsele H; Spencer A; Hajek R; Jurczyszyn A; et alii...

Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations. in British journal of haematology / Br J Haematol. 2021 Aug;194(3):496-507. doi: 10.1111/bjh.17338. Epub 2021 Mar 16.
2021
AOU Città della Salute di Torino

Sezer O; Sonneveld P; Reece D; Rasche L; Moreau P; Mohty M; Merlini G; Lentzsch S; Mateos MV; Leleu X; Leal da Costa F; Kyle RA; Kröger N; Jurczyszyn A; Hungria V; Hájek R; Gay F; Gahrton G; Fernández de Larrea C; Engelhardt M; Dispenzieri A; Einsele H; Dimopoulos MA; Cavo M; Caers J; Badros A; Anderson KC; Van de Donk NWCJ; Zamagni E; et alii...

Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysis. in JAMA oncology / JAMA Oncol. 2018 Oct 1;4(10):1389-1397. doi: 10.1001/jamaoncol.2018.2961.
2018
AOU Città della Salute di Torino

Gay F; Jackson G; Rosiñol L; Holstein SA; Moreau P; Spada S; Davies F; Lahuerta JJ; Leleu X; Bringhen S; Evangelista A; Hulin C; Panzani U; Cairns DA; Di Raimondo F; Macro M; Liberati AM; Pawlyn C; Offidani M; Spencer A; Hájek R; Terpos E; Morgan GJ; Bladé J; Sonneveld P; San-Miguel J; McCarthy PL; Ludwig H; Boccadoro M; et alii...

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. in The Lancet. Oncology / Lancet Oncol. 2014 Nov;15(12):e538-48. doi: 10.1016/S1470-2045(14)70442-5. Epub 2014 Oct 26.
2014
AOU Città della Salute di Torino

Rajkumar SV; Dimopoulos MA; Palumbo A; Blade J; Merlini G; Mateos MV; Kumar S; Hillengass J; Kastritis E; Richardson P; Landgren O; Paiva B; Dispenzieri A; Weiss B; LeLeu X; Zweegman S; Lonial S; Rosinol L; Zamagni E; Jagannath S; Sezer O; Kristinsson SY; Caers J; Usmani SZ; Lahuerta JJ; Johnsen HE; Beksac M; Cavo M; Goldschmidt H; et alii...